PharmaCyte Biotech, Inc. SEC filings PMCB
PharmaCyte Biotech, Inc. has 472 filings in SEC EDGAR's recent list, going back to Aug 20, 2001. Its latest annual report, Form 10-K, was filed on Jul 29, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (auditor change). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Sep 17, 2025 | — |
| S-8 | Employee stock plan registration | Dec 4, 2024 | — |
| S-3/A | Filing | Sep 21, 2023 | — |
| S-3/A | Amendment 2 | Sep 12, 2023 | — |
| S-3/A | Amendment no. 1 | Aug 4, 2023 | — |
| S-3 | Shelf registration | Jun 9, 2023 | — |
| 424B3 | Prospectus | Nov 22, 2021 | — |
| S-3 | Shelf registration | Nov 8, 2021 | — |
| 424B5 | Prospectus supplement | Aug 23, 2021 | — |
| S-3MEF | Form s-3 mef | Aug 19, 2021 | — |
| 424B5 | Prospectus supplement | Aug 10, 2021 | — |
| 424B5 | Prospectus supplement | Aug 2, 2021 | — |
| S-3 | Shelf registration | Apr 5, 2021 | — |
| 424B5 | Prospectus supplement | Feb 22, 2018 | — |
| 424B3 | Prospectus | Sep 28, 2017 | — |
| S-3 | Shelf registration | Sep 13, 2017 | — |
| 424B5 | Prospectus supplement | Dec 2, 2014 | — |
| 424B5 | Prospectus supplement | Nov 12, 2014 | — |
| 424B2 | Prospectus | Oct 29, 2014 | — |
| S-3/A | Amendment no. 1 | Oct 24, 2014 | — |
| S-3 | Shelf registration | Oct 17, 2014 | — |
| S-8 POS | Filing | Feb 9, 2006 | — |
| S-8 POS | Filing | Nov 2, 2005 | — |
| S-8 POS | Filing | Jul 18, 2005 | — |
| S-8 | Employee stock plan registration | Jun 15, 2005 | — |
| 424B3 | Prospectus | Nov 3, 2004 | — |
| S-8 | Employee stock plan registration | Aug 30, 2004 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PMCB (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1157075
- Former names
- NUVILEX, INC. (until Jan 9, 2015); EFOODSAFETY COM INC (until Mar 17, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.